| Literature DB >> 36231124 |
Paola Rebuzzini1, Gemma Fabozzi2, Danilo Cimadomo2, Filippo Maria Ubaldi2, Laura Rienzi2,3, Maurizio Zuccotti1,4, Silvia Garagna1,4.
Abstract
Environmental toxicants (ETs) are an exogenous chemical group diffused in the environment that contaminate food, water, air and soil, and through the food chain, they bioaccumulate into the organisms. In mammals, the exposure to ETs can affect both male and female fertility and their reproductive health through complex alterations that impact both gametogeneses, among other processes. In humans, direct exposure to ETs concurs to the declining of fertility, and its transmission across generations has been recently proposed. However, multi- and transgenerational inheritances of ET reprotoxicity have only been demonstrated in animals. Here, we review recent studies performed on laboratory model animals investigating the effects of ETs, such as BPA, phthalates, pesticides and persistent contaminants, on the reproductive system transmitted through generations. This includes multigenerational effects, where exposure to the compounds cannot be excluded, and transgenerational effects in unexposed animals. Additionally, we report on epigenetic mechanisms, such as DNA methylation, histone tails and noncoding RNAs, which may play a mechanistic role in a nongenetic transmission of environmental information exposure through the germline across generations.Entities:
Keywords: endocrine-disrupting compounds; environmental toxicants; epigenetic inheritance; fertility; folliculogenesis; multigenerational effect; oocyte; reproduction; sperm; spermatogenesis; transgenerational effect
Mesh:
Substances:
Year: 2022 PMID: 36231124 PMCID: PMC9563050 DOI: 10.3390/cells11193163
Source DB: PubMed Journal: Cells ISSN: 2073-4409 Impact factor: 7.666
Figure 1Schematic representation of the (A) multigenerational and (B) transgenerational transmission of ETs effects. F0: parental generation; F1: first filial generation: F2: second filial generation; F3: third filial generation.
Phytoestrogens and Mycotoxins-Induced Effects In Model Animals Across Generations.
| Species | Sex | Exposure | Dose | Effects across Generations | Reference |
|---|---|---|---|---|---|
| Mouse | Male | Genistein | 40 mg/kg BW */day | F1: increased serum testosterone levels (40 mg/kg); increased testis weight (40 mg/kg); decreased testis weight (800 mg/kg); higher diameter of seminiferous tubules (40 mg/kg); increased heights of seminiferous epithelium (40 mg/kg day); smaller diameter of seminiferous tubules (800 mg/kg); increased | [ |
| Rat | Male | Genistein | 1 mg/kg BW/day | F1: increased expression of | [ |
| Rat | Female | Zearalenone | 5, 10, and 20 mg/kg | F1: increase of follicle-stimulating hormone concentration (10 and 20 mg/kg); estradiol decrease (10 and 20 mg/kg); follicular atresia (20 mg/kg); thin uterine layer (20 mg/kg); reduced expression of estrogen receptor-alpha (10 and 20 mg/kg) in the placenta; reduced expression of gonadotropin-releasing hormone receptor (10 and 20 mg/kg) in the placenta | [ |
| Mouse | Male | Zearalenone | 20 µg/kg BW/day 40 µg/kg BW/day | F1: decreased sperm motility; decreased sperm concentration (all doses); reduced testis weight (all doses); percentage alteration in the of cells at different stages of meiosis (increased percentage of leptotene cells; decreased percentage of diplotene cells; all doses); reduction of 5hmC (all doses) in the testis; increased percentage of H3K27me3-positive spermatogonial cells (all doses); increased expression of H3K9 in the testis; increased expression of G9a in the testis; reduced percentage of ERα-positive Leydig cells (all doses) | [ |
| Mouse | Male | Zearalenone | 2.5 and 5.0 mg/kg BW/day | F1: abnormal vacuole structures; testes loose connections (all doses); decreased semen quality (all doses); decreased sperm count (all doses); decreased testosterone levels (all doses) | [ |
* BW: body weight.
BPA-Induced Effects In Model Animals Across Generations.
| Species | Sex | Exposure | Dose | Effects across Generations | Reference |
|---|---|---|---|---|---|
| Mouse | Male | From E7 to E14 | 50 μg, 5 mg, and 50 mg/kg BW */day | F1: reduced testis weight (50 mg/kg at PND + 30; 5 and 50 mg/kg at PND 60); alterations in seminiferous epithelial stages (all doses at both PND 30 and PND 60) (increased lumen area of stage VII; decreased lumen area of stage VIII); apoptosis of germ cells (5 and 50 mg/kg); | [ |
| Mouse | Male | From E7 to E14 | 50 μg, 5 mg, and 50 mg/kg BW/day | F1: decreased frequency of stage VIII testicular seminiferous epithelial cells (5 and 50 mg/kg); increased number of abnormal seminiferous tubules (5 and 50 mg/kg); decreased sperm count (5 and 50 mg/kg); decreased sperm motility (50 mg/kg); altered DNA methylation in spermatozoa (5 and 50 mg/kg); proteomic expression changes in spermatozoa (50 mg/kg) | [ |
| Rat | Male | From E8 to 14 | Mixture: | F3: pubertal abnormalities; testis dysfunction; apoptosis of spermatogenic cell; differential DNA methylated regions in spermatozoa | [ |
| Rat | Male | Continuous during the whole fetal life | 0.5 mg/kg BW/day | F0 and F1: changes in lipid metabolism in the testis; altered protein secondary structures in the testis; decreased testosterone production | [ |
| Rat | Female | From E8 to 14 | 50 mg/kg BW/day | F3: pubertal abnormalities; primary ovarian insufficiency; polycystic ovaries | [ |
| Mouse | Female | From E11 to birth | 0.5, 20, 50 µg/kg BW/day | F1: inhibited ovarian germ cell nest breakdown (all doses); decreased fertility (all doses); reduced litter size (50 μg/kg); reduction of primordial follicles number and increase of primary follicles (0.5 and 50 µg/kg); increase of preantral follicles (high doses); altered estradiol levels (20 µg/kg); increased expression of steroidogenic enzymes and steroidogenesis-related genes ( | [ |
+ PND: postnatal day; * BW: body weight.
Phthalate-induced effects in model animals across generations.
| Species | Sex | Exposure | Dose | Effects across Generations | Reference |
|---|---|---|---|---|---|
| Mouse | Male | DEHP | 500 mg/kg | F1–F4: disruption of testicular germ cell association; reduced sperm motility | [ |
| Mouse | Male | DEHP | 20, 200 μg/kg/day | F3: decreased fertility (20 µg/kg); reduced testicular steroidogenic capacity (20 and 200 μg/kg); impaired spermatogenesis (20 and 200 μg/kg); decreased sperm concentration (20 and 200 μg/kg); decreased sperm motility (20 and 200 μg/kg); alteration of BTB integrity (20 and 200 μg/kg); alteration of Y genes expression (20 and 200 μg/kg) in the testis | [ |
| Rat | Male | DBP | 500 mg/kg | F1–F3: spermatogenesis failure; altered reproduction; decrease sperm count; reduced Sertoli cells number; metabolic changes in the testis (increase level of betaine; drop of betaine homocysteine S-methyltransferase); DNA hypomethylation (in TM-4 cells, an immortalized cell line derived from mouse testis). | [ |
| Mouse | Female | DEHP | 80 mg/kg/day | F0–F2: reduced expression of Esr1 in the ovary | [ |
| Rat | Female | DEHP | 1, 10, and 100 mg/kg/BW * | F0: decrease of estradiol (all doses), testosterone and progesterone levels (10 and 100 mg/kg) | [ |
| Mouse | Female | DEHP | 20, 200 µg/kg/day | F1: estrous cyclicity impairment (750 mg/kg); increased ovarian cysts number (750 mg/kg); total follicle number decrease (750 mg/kg); increased estradiol levels (500 and 750 mg/kg); decreased testosterone (500 mg/kg), inhibin B (750 mg/kg) and FSH levels (500 mg/kg); increased LH levels (20 µg/kg) | [ |
| Mouse | Female | DEHP | 20 and 200 μg/kg/day | F1: accelerated puberty onset (200 µg/kg); disrupted estrous cyclicity (200 µg and 500 mg/kg); altered folliculogenesis (20 and 200 µg/kg); increased Dnmt expression in the ovary (750 mg/kg); increased presence of 5-mC in the ovary (20 µg/kg). | [ |
| Mouse | Female | From E10 to birth | Mixture of 20 and 200 μg/kg/day—200 and 500 mg/kg/day [DEP (35.22%), DEHP (21.03%), DBP (14.91%), DiBP (8.61%), DiNP (15.10 %), and BzBP (5.13 %)] | F1: decreased FSH (500 mg/kg), estradiol (20 µg/kg; 200 and 500 mg/kg) testosterone (200 µg/kg; 200 and 500 mg/kg levels) and progesterone (500 mg/kg) levels; decreased steroidogenesis (20 and 200 µg/kg; 500 mg/kg); altered transition among follicle types (20 μg/kg and 200 mg/kg); higher incidence of atresia (500 mg/kg) | [ |
| Mouse | Female | DEHP | 0.05, 5 mg/kg/day | F1-F3: accelerated follicular recruitment (all doses); reduction of primordial follicular reserve (all doses); increased pre-antral follicles number (all doses); diminished oocyte quality (0.05 mg/kg); diminished embryonic developmental competence (0.05 mg/kg); altered expression profile of ovarian and pre-implantation embryonic genes, observed in the ovary and in blastocysts, respectively (all doses) | [ |
+ PND: postnatal day; * BW: body weight.
Pesticide-induced effects in model animals across generations.
| Species | Sex | Exposure | Dose | Effects across Generations | Reference |
|---|---|---|---|---|---|
| Rat | Male | Atrazine | 25 mg/kg BW/day | F2 and F3: azoospermia; atretic seminiferous tubules; vacuoles in the basal region of seminiferous tubules; sloughed germ cells; lack of seminiferous tubule lumen; high frequency of spermatogonia apoptosis; mammary tumors; early onset puberty; epimutations in spermatozoa | [ |
| Rat | Male | Vinclozolin | 100 mg/kg/ day | F1: lowest number of DMRs in spermatozoa; altered quantity of lncRNA in spermatozoa | [ |
| Mouse/Rat | Male | Vinclozolin | 100 mg/kg/ day (rat) | F1–F3: increased spermatogenic cell apoptosis; decreased sperm number and motility; drop of epididymal sperm number; epigenetic alterations in spermatozoa (DMRs modified) (all doses) | [ |
| Rat | Male | DDT | 25 mg/kg BW/day | F1–F3: altered DNA methylation; altered noncoding RNAs expression in spermatozoa | [ |
| Rat | Male | DDE | 100 mg/kg BW/day | F1 and F2: downregulation of DNMT1 and DNMT3 in the testis | [ |
| Mouse | Female | Vinclozolin | 50 mg/kg BW/day | F3: polycystic ovary | [ |
| Rat | Female | Vinclozolin or DDT | 100 mg/kg BW/day (Vinclozolin) | F3: differentially methylated regions in granulosa cells; altered expression of RNAs (492 sncRNAs and 123 lncRNAs in the vinclozolin-exposed granulosa cells; 1085 sncRNAs and 51 lncRNAs in the DDT granulosa cells; 174 mRNAs in vinclozolin-exposed granulosa cells; 212 mRNAs in DDT-exposed granulosa cells; predisposition to ovarian diseases) | [ |
BW: body weight.
Persistent environmental contaminant-induced effects in model animals across generations.
| Species | Sex | Exposure | Dose | Effects across Generations | Reference |
|---|---|---|---|---|---|
| Rat | Male | TCDD | 100 ng/kg BW */day | F3: sperm epigenome alteration; reduction of testosterone levels | [ |
| Rat | Male | A1221 (mixture of PCBs) | 1 mg/kg BW/day | F1 and F3: epigenetic alterations in spermatozoa (DMRs modified) | [ |
| Rat | Male | POP mixture (polychlorinated biphenyls and organochlorine pesticides) | 500 µg/kg BW three times a week for 5 weeks, before mating through mating and parturition of the F1 litters | F1: decreased conception; decreased fertility; reduced number of fetuses; low sperm quality; advanced puberty; lower testosterone concentration; small epididymis; low prostate weights; reduced sperm counts; reduced sperm motility; hyper-methylation of | [ |
| Mouse | Male | PCBs (mixture of two congeners) | 0, 1, 10, and 100 µg PCB/kg BW/day | F1 and F2: reduced testis weight (all doses); reduced seminiferous tubule diameter (all doses); low sperm viability (all doses); reduced fertility (all doses) | [ |
| Rat | Female | TCDD | 100 ng/kg BW/day | F1: primordial follicle loss; polycystic ovary disease | [ |
| Mouse | Female | TCDD on E15.5 | 10 µg/kg BW/day | F3: adenomyosis; reduced fertility; dysmenorrhea; preterm birth | [ |
| Rat | Female | A1221 from E16 to E18 | 1 mg/kg BW/day | F2 and F3: altered serum progesterone and estradiol levels; low fertility | [ |
| Mouse | Female | PCBs (mixture of two congeners) | 0, 1, 10, and 100 µg/kg BW/day | F1: reduced ovary weight (all doses); low oocyte developmental capacity (100 µg/kg); increased follicular atresia (all doses); smaller litters (all doses) | [ |
+ PND: postnatal day; * BW: body weight.
Figure 2EDC exposure may alter DNA methyltransferases, histone modifiers and noncoding RNAs with downstream effects on the gene expression.